# How Cannabis Is Being Used in Therapeutic Treatments – Breaking AC > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-therapeutic-treatments-research-insights/ > **Published:** 2026-03-14T18:48:57-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:58:48-04:00 > **Clinical Summary:** Explore cannabis therapeutic treatments and current research on its role in pain management and clinical applications. --- ✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PainResearchTHCCBDSafety Clinical Summary # Clinical Summary Cannabis is increasingly being explored as a potential therapeutic agent for pain management, with anecdotal reports from patients suggesting symptom relief, though rigorous clinical evidence remains limited. Current research indicates that cannabinoids may modulate pain signaling through interactions with the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/), but the precise mechanisms of action and optimal dosing regimens require further investigation. The gap between patient-reported benefits and robust clinical data underscores the importance of well-designed randomized controlled trials to establish efficacy, safety profiles, and appropriate patient selection criteria. Clinicians should remain cautious about recommending [cannabis for pain management](https://cedclinic.com/medical-cannabis-patient-benefits/) until higher-quality evidence emerges, while acknowledging that some patients may seek this option and benefit from informed discussion about known risks and limited evidence. For now, physicians should encourage patients to discuss cannabis use openly and stay informed about evolving research to integrate any validated applications into comprehensive pain management strategies. Dr. Caplan’s Take “After two decades of clinical practice, I can tell you that cannabis does modulate pain signaling in meaningful ways for certain patients, particularly those with neuropathic pain or chemotherapy-induced symptoms, but we’re still operating with incomplete evidence about dosing, delivery methods, and long-term outcomes, which is why I treat it as a legitimate therapeutic option rather than a panacea.” Clinical Perspective While anecdotal reports and preliminary research suggest cannabis may have analgesic properties through interactions with endocannabinoid signaling pathways, clinicians should recognize that evidence remains limited and heterogeneous, with most high-quality trials restricted to specific conditions like chemotherapy-induced nausea or certain neuropathic pain syndromes. Patient expectations often outpace the current evidence base, and individual responses vary considerably depending on cannabinoid composition, dosing, route of administration, and underlying comorbidities—factors that are rarely standardized in patient self-management. Additionally, potential drug interactions, cognitive effects, and long-term safety data remain incompletely characterized, particularly for chronic use in vulnerable populations. Until more rigorous [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) establish efficacy and safety profiles for specific indications, practitioners should engage in shared decision-making with patients interested in cannabis, document use patterns clearly, and maintain awareness that cannabis may be used as a 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/pain-management/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+How+Cannabis+Is+Being+Used+in+Therapeutic+Treatments+-+Breaking+AC+%40drcaplan&url=https%3A%2F%2Fbreakingac.com%2Fnews%2F2026%2Fmar%2F13%2Fhow-cannabis-is-being-used-in-therapeutic-treatments%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fbreakingac.com%2Fnews%2F2026%2Fmar%2F13%2Fhow-cannabis-is-being-used-in-therapeutic-treatments%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+How+Cannabis+Is+Being+Used+in+Therapeutic+Treatments+-+Breaking+AC+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fbreakingac.com%2Fnews%2F2026%2Fmar%2F13%2Fhow-cannabis-is-being-used-in-therapeutic-treatments%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) - [CED Digest: 392 Items — March 11, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [In the Mix: 31 More Articles — March 04, 2026](https://cedclinic.com/cannabis-articles-clinical-relevance-march-04-2026/) 📰 Source: [https://breakingac.com/news/2026/mar/13/how-cannabis-is-being-used-in-therapeutic-treatments/](https://breakingac.com/news/2026/mar/13/how-cannabis-is-being-used-in-therapeutic-treatments/) Further Reading Evidence Watch[Cannabinoid Clinical Trials: CBD Cortical Excitability Study](https://cedclinic.com/cannabidiol-lacks-intrinsic-anti-epileptic-properties-trial/) CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) Research Digest[AM Policy Update: March 11, 2026](https://cedclinic.com/dea-rescheduling-marijuana-march-11-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Endocannabinoid System Research: Cannabis for Chronic Pain](https://cedclinic.com/cannabinoids-chronic-pain-evidence-review-2025-2/) Explore how cannabis interacts with the endocannabinoid system to potentially alleviate chronic pain symptoms. [Read More](https://cedclinic.com/cannabinoids-chronic-pain-evidence-review-2025-2/) [Endocannabinoid System Research: Cannabis Mental Health Care](https://cedclinic.com/clinical-trial-cannabis-mental-health-research/) Review current findings on cannabis use in mental health care and its therapeutic implications. [Discover Insights](https://cedclinic.com/clinical-trial-cannabis-mental-health-research/) [Cannabinoid Clinical Trials for Mental Disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-efficacy/) An overview of clinical trials investigating cannabinoids for various [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/). [Learn More](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-efficacy/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).